Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry. - Wikidata - awgldk - TriplyDB

Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

http://www.wikidata.org/entity/Q34448350

about

Medical treatment update on pulmonary arterial hypertension The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension.Predicting the Need for Upfront Combination Therapy in Pulmonary Arterial Hypertension.Update on Pulmonary Arterial Hypertension Research: Proceedings from a Meeting of Experts.Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes.Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial.

P2860

Q26785995-39944785-064F-4737-BB49-1EFCB8B01468 Q33788447-4A362464-3F9F-4BE2-8109-D7BAF066D5E4 Q38329154-CFFD5FD1-721A-49B2-910A-7A0BA4F44E26 Q46229295-04122EFE-ABEA-4C08-81BF-76AB64AB3459 Q47102317-BF761170-6133-485E-BB7E-47DAED98AC02 Q47245549-CC8FB04A-FBF5-4168-A727-73AA52209D54

P2860

Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

http://www.wikidata.org/entity/Q34448350

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Characterization of first-time ...... ension in the REVEAL registry.

@ast

Characterization of first-time ...... ension in the REVEAL registry.

@en

Characterization of first-time ...... ension in the REVEAL registry.

@nl

type

label

Characterization of first-time ...... ension in the REVEAL registry.

@ast

Characterization of first-time ...... ension in the REVEAL registry.

@en

Characterization of first-time ...... ension in the REVEAL registry.

@nl

prefLabel

Characterization of first-time ...... ension in the REVEAL registry.

@ast

Characterization of first-time ...... ension in the REVEAL registry.

@en

Characterization of first-time ...... ension in the REVEAL registry.

@nl

P1433

Q34448350-89A50086-1D19-4CB3-B12E-147A71CAF038

P1476

Q34448350-CD80A706-BC16-4A0C-85E9-25CB89751028

P2093

Q34448350-0952A3B1-47DF-4F63-852C-98D9C9BCD52C

Q34448350-2BDFCC64-25F9-453E-AC7A-FC24214F651B

Q34448350-39AFED38-7874-4939-97A5-73721DA38661

Q34448350-6DA77D85-8D94-4C83-AAA9-13A8365F29BA

Q34448350-C4D84CB7-472C-45E6-92C6-77552049D6A8

Q34448350-CE63AAF9-F138-4738-97AE-18A4B0E377D0

Q34448350-ED5BF6EB-944F-4D1A-A27F-09DD942C76E1

Q34448350-F1CC00E5-F7EF-4A48-A7ED-3C3B58610431

P2860

Q34448350-00F17672-AE06-4204-AE21-06A789CB066C

Q34448350-13C398D2-F89E-476B-984A-C75687C20511

Q34448350-1A025ACC-B96B-48C1-81F5-E2DC1F8B1FD5

Q34448350-703A178D-D2FF-4E8A-B7CA-380FCB2A97BB

Q34448350-83B13264-D7B9-4FAA-8CD2-75E1B47369A3

Q34448350-92A3BE00-2939-44C8-87B5-E994E726BBBF

Q34448350-9675E51A-076F-4B71-AF3C-177C5974155B

Q34448350-9AAA80A5-6D02-451D-9FEC-3FA9D3B0D231

Q34448350-BF1D3ABF-CF69-4D28-992B-1684FEF69B5B

Q34448350-DD7F3226-8C78-4A5D-B5DF-93C0991B1A05

P304

Q34448350-5CC386CD-3555-40CC-818E-22E755DE0EBC

P31

Q34448350-88391E87-D4E8-41C6-ACCA-231207556BC2

P356

Q34448350-5E4E18D0-F33D-4113-B492-72DE7FACE981

P407

Q34448350-C5499679-9CB5-4369-86A1-66AD1D9EFA90

P433

Q34448350-E9A25A35-F8B3-45C7-9AB1-3F16435E3E58

P478

Q34448350-3CB1A612-96D7-4049-893F-D45AB7F3DEA7

P577

Q34448350-F2DC738F-4973-4AF3-871F-0289D9C93D37

P5875

Q34448350-461FCC3C-0D04-4F64-B19E-A606796FC06C

P698

Q34448350-95697310-B6E7-459C-BD13-F89C9F90E25A

P921

Q34448350-D32F7C2C-89EA-431F-A2E1-B85DE7FDBEE6

P932

Q34448350-218F5FB4-2006-4A56-AFCA-7AB9AF6896D4

P356

P1433

P1476

Characterization of first-time ...... ension in the REVEAL registry.

@en

P2093

Alain J Romero

http://www.w3.org/2001/XMLSchema#string

Charles D Burger

http://www.w3.org/2001/XMLSchema#string

Dave P Miller

http://www.w3.org/2001/XMLSchema#string

Michael D McGoon

http://www.w3.org/2001/XMLSchema#string

Monarch R Shah

http://www.w3.org/2001/XMLSchema#string

Pamela K Long

http://www.w3.org/2001/XMLSchema#string

Robert E Safford

http://www.w3.org/2001/XMLSchema#string

Wade W Benton

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Clinical classification of pulmonary hypertension.

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Biomarkers and surrogate endpoints in clinical trials

Heart failure–associated hospitalizations in the United States.

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.

Macitentan and morbidity and mortality in pulmonary arterial hypertension.

P304

1263-1273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.14-0193

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262886017

http://www.w3.org/2001/XMLSchema#string

P698

24901386

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

4219341

http://www.w3.org/2001/XMLSchema#string